Genetics Signatures chair Caroline Waldron says US sales of the molecular diagnostics Easyscreen test have disappointed, but a revamped strategy should right the wrongs.
WWI CEO Rudi Deysel chats with Tylah Tully to recap a pivotal September quarter, during which the company officially became an operating gold producer in the Witwatersrand Basin.